Tactile Systems Technology, Inc. Equity Securities without Readily Determinable Fair Value, Amount
Tactile Systems Technology, Inc. (TCMD) had Equity Securities without Readily Determinable Fair Value, Amount of $300.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2026-02-17
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Amount $300.00K.
- 2024-12-31: Equity Securities without Readily Determinable Fair Value, Amount $300.00K.
- 2023-12-31: Equity Securities without Readily Determinable Fair Value, Amount $300.00K.
- 2022-12-31: Equity Securities without Readily Determinable Fair Value, Amount $300.00K.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount | Equity Securities without Readily Determinable Fair Value, Amount as first filed |
|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-02-17 | |
| 2024-12-31 | $300.00K 10-K · filed 2026-02-17 | |
| 2023-12-31 | $300.00K 10-K · filed 2025-02-18 | |
| 2022-12-31 | $300.00K 10-K · filed 2024-02-20 | |
| 2021-12-31 | $300.00K 10-K · filed 2023-02-21 | |
| 2020-12-31 | $300.00K 10-K · filed 2021-02-23 | |
| 2019-12-31 | $700.00K 10-K · filed 2021-02-23 | $650.00K 10-K · filed 2020-02-26 |
| 2018-12-31 | $650.00K 10-K · filed 2020-02-26 | |
| 2017-12-31 | $150.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |